Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07051655 · ClinicalTrials.gov registry record · NA
The Effects of Exogenous Ketones on Cognitive Function
A NA study of Placebo - Control and Ketone Monoester, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT07051655 is a NA study of Placebo - Control and Ketone Monoester that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07051655, a NA study of Placebo - Control and Ketone Monoester, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the acute effects of exogenous ketone monoester (KME) supplementation on cognitive function in three groups of adults aged 19-55 years: (1) obese, sedentary individuals; (2) lean, sedentary individuals; and (3) lean individuals who engage in regular physical activity (e.g., collegiate or amateur athletes). The main questions it aims to answer are to: * Assess the effects of acute KME supplementation versus placebo on cognitive, sensorimotor, and functional outcomes within groups. * Compare cognitive performance across the three groups. The primary outcome is cognitive performance assessed using the NIH Toolbox Cognition Battery. Secondary Outcomes include sensorimotor performance, measured using the Senaptec Sensory System, and driving performance, assessed with a driving simulator.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Ketone Monoester (KE)
Study Locations (1)
Alabama
- 916 Building - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07051655
The ClinicalTrials.gov registry entry for NCT07051655 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Placebo - Control appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07051655 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT07051655 about?
NCT07051655 is a clinical study titled "The Effects of Exogenous Ketones on Cognitive Function". The purpose of this study is to evaluate the acute effects of exogenous ketone monoester (KME) supplementation on cognitive function in three groups of adults aged 19-55 years: (1) obese, sedentary individuals; (2) lean, sedentary individuals; and (3) lean individuals who engage in regular physical ...
What is the current status of trial NCT07051655?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-12-01. Estimated completion is 2026-04.
What conditions does trial NCT07051655 study?
This clinical trial studies the following conditions: Placebo - Control, Ketone Monoester.
What interventions are being tested in trial NCT07051655?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Ketone Monoester (KE) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07051655?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07051655 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Placebo - Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.